The Tell-tale heart: Population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction
PLoS ONE, ISSN: 1932-6203, Vol: 2, Issue: 9, Page: e840
2007
- 54Citations
- 66Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations54
- Citation Indexes52
- 52
- CrossRef36
- Clinical Citations1
- PubMed Guidelines1
- Policy Citations1
- Policy Citation1
- Captures66
- Readers66
- 66
Article Description
Background. COX-2 selective inhibitors are associated with myocardial infarction (MI). We sought to determine whether population health monitoring would have revealed the effect of COX-2 inhibitors on population-level patterns of MI. Methodology/Principal Findings. We conducted a retrospective study of inpatients at two Boston hospitals, from January 1997 to March 2006. There was a population-level rise in the rate of Mi that reached 52.0 MI-related hospitalizations per 100,000 (a two standard deviation exceedence) in January of 2000, eight months after the introduction of rofecoxib and one year after celecoxib. The exceedence vanished within one month of the withdrawal of rofecoxib. Trends in inpatient stay due to MI were tightly coupled to the rise and fall of prescriptions of COX-2 inhibitors, with an 18.5% increase in inpatient stays for MI when both rofecoxib and celecoxib were on the market (P<0.001). For every million prescriptions of rofecoxib and celecoxib, there was a 0.5% increase in MI (95%Cl 0.1 to 0.9) explaining 50.3% of the deviance in yearly variation of Mi-related hospitalizations. There was a negative association between mean age at MI and volume of prescriptions for celecoxib and rofecoxib (Spearman correlation, -0.67, P<0.05). Conclusions/Significance. The strong relationship between prescribing and outcome time series supports a population-level impact of COX-2 inhibitors on MI incidence. Further, mean age at MI appears to have been lowered by use of these medications. Use of a population monitoring approach as an adjunct to pharmacovigilence methods might have helped confirm the suspected association, providing earlier support for the market withdrawal of rofecoxib. © 2007 Brownstein et al.
Bibliographic Details
10.1371/journal.pone.0000840; 10.1371/journal.pone.0000840.g002; 10.1371/journal.pone.0000840.g001; 10.1371/journal.pone.0000840.t001; 10.1371/journal.pone.0000840.g003; 10.6084/m9.figshare.88829; 10.6084/m9.figshare.18505; 10.6084/m9.figshare.88789
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=41049092271&origin=inward; http://dx.doi.org/10.1371/journal.pone.0000840; http://www.ncbi.nlm.nih.gov/pubmed/17786211; https://dx.plos.org/10.1371/journal.pone.0000840.g002; http://dx.doi.org/10.1371/journal.pone.0000840.g002; https://dx.plos.org/10.1371/journal.pone.0000840.g001; http://dx.doi.org/10.1371/journal.pone.0000840.g001; https://dx.plos.org/10.1371/journal.pone.0000840.t001; http://dx.doi.org/10.1371/journal.pone.0000840.t001; https://dx.plos.org/10.1371/journal.pone.0000840.g003; http://dx.doi.org/10.1371/journal.pone.0000840.g003; https://dx.plos.org/10.1371/journal.pone.0000840; https://doi.org/10.6084%2Fm9.figshare.88829; https://doi.org/10.6084%2Fm9.figshare.18505; https://doi.org/10.6084%2Fm9.figshare.88789; https://dx.doi.org/10.1371/journal.pone.0000840.t001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0000840.t001; https://dx.doi.org/10.1371/journal.pone.0000840; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000840; https://dx.doi.org/10.1371/journal.pone.0000840.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0000840.g002; https://dx.doi.org/10.1371/journal.pone.0000840.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0000840.g001; http://dx.doi.org/10.6084/m9.figshare.18505; https://dx.doi.org/10.6084/m9.figshare.18505; http://dx.doi.org/10.6084/m9.figshare.88789; https://dx.doi.org/10.6084/m9.figshare.88789; https://dx.doi.org/10.1371/journal.pone.0000840.g003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0000840.g003; http://dx.doi.org/10.6084/m9.figshare.88829; https://dx.doi.org/10.6084/m9.figshare.88829; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0000840&type=printable; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0000840; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0000840&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000840; http://dx.plos.org/10.1371/journal.pone.0000840.t001; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0000840; http://dx.plos.org/10.1371/journal.pone.0000840.g001; http://dx.plos.org/10.1371/journal.pone.0000840.g003; http://dx.plos.org/10.1371/journal.pone.0000840.g002; http://dx.plos.org/10.1371/journal.pone.0000840
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know